CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C21204 | BRD-K59196623 | BRD-K59196623 | -- | -- | -- | Details |
| C21205 | BRD-K59196958 | SA-1938421 | -- | -- | -- | Details |
| C21206 | BRD-K59197931 | naproxen | PTGS1; PTGS2 | Cyclooxygenase inhibitor | -- | Details |
| C21207 | BRD-K59201357 | BRD-K59201357 | -- | -- | -- | Details |
| C21208 | BRD-K59203806 | hydrocinnamic-acid | -- | -- | -- | Details |
| C21209 | BRD-K59204160 | BRD-K59204160 | -- | -- | -- | Details |
| C21210 | BRD-K59204667 | DBeQ | CASP3 | ATPase inhibitor | dbeq | Details |
| C21211 | BRD-K59205024 | BRD-K59205024 | -- | -- | -- | Details |
| C21212 | BRD-K59207957 | BRD-K59207957 | -- | -- | -- | Details |
| C21213 | BRD-K59221664 | BRD-K59221664 | -- | -- | -- | Details |
| C21214 | BRD-K59222562 | BRD-K59222562 | CLK1; DYRK1A; CLK4; DYRK1B | DYRK inhibitor | -- | Details |
| C21215 | BRD-K59227464 | LY-2228820 | -- | -- | -- | Details |
| C21216 | BRD-K59230034 | BRD-K59230034 | -- | -- | -- | Details |
| C21217 | BRD-K59232896 | BRD-K59232896 | -- | -- | -- | Details |
| C21218 | BRD-K59239787 | BRD-K59239787 | -- | -- | -- | Details |
| C21219 | BRD-K59239976 | BRD-K59239976 | -- | -- | -- | Details |
| C21220 | BRD-K59247792 | BRD-K59247792 | -- | -- | -- | Details |
| C21221 | BRD-K59248078 | BRD-K59248078 | -- | -- | -- | Details |
| C21222 | BRD-K59248941 | BRD-K59248941 | -- | -- | -- | Details |
| C21223 | BRD-K59250830 | BRD-K59250830 | -- | -- | -- | Details |
| C21224 | BRD-K59253994 | BRD-K59253994 | -- | -- | -- | Details |
| C21225 | BRD-K59255802 | BRD-K59255802 | -- | -- | -- | Details |
| C21226 | BRD-K59256312 | gabexate | PRSS1 | Serine protease inhibitor | -- | Details |
| C21227 | BRD-K59261651 | BRD-K59261651 | -- | -- | -- | Details |
| C21228 | BRD-K59261663 | BRD-K59261663 | -- | -- | -- | Details |
| C21229 | BRD-K59263278 | BRD-K59263278 | -- | -- | -- | Details |
| C21230 | BRD-K59272984 | BRD-K59272984 | -- | -- | -- | Details |
| C21231 | BRD-K59273480 | propentofylline | PDE1A | Phosphodiesterase inhibitor; Adenosine reuptake inhibitor | -- | Details |
| C21232 | BRD-K59283736 | BRD-K59283736 | -- | -- | -- | Details |
| C21233 | BRD-K59284035 | chrysophanic-acid | EGFR; MTOR | EGFR inhibitor | -- | Details |
| C21234 | BRD-K59291587 | BRD-K59291587 | -- | -- | -- | Details |
| C21235 | BRD-K59294904 | BRD-K59294904 | -- | -- | -- | Details |
| C21236 | BRD-K59304176 | GO-6976 | -- | -- | -- | Details |
| C21237 | BRD-K59308946 | BRD-K59308946 | -- | -- | -- | Details |
| C21238 | BRD-K59314947 | BRD-K59314947 | -- | -- | -- | Details |
| C21239 | BRD-K59317601 | MLN-0128 | -- | -- | -- | Details |
| C21240 | BRD-K59323544 | BRD-K59323544 | -- | -- | -- | Details |
| C21241 | BRD-K59324394 | BRD-K59324394 | -- | -- | -- | Details |
| C21242 | BRD-K59324446 | BRD-K59324446 | -- | -- | -- | Details |
| C21243 | BRD-K59325863 | delanzomib | -- | -- | -- | Details |
| C21244 | BRD-K59330510 | BRD-K59330510 | -- | -- | -- | Details |
| C21245 | BRD-K59331299 | voglibose | GAA; MGAM | Glucosidase inhibitor | -- | Details |
| C21246 | BRD-K59331372 | SB-366791 | TRPV1 | TRPV antagonist | -- | Details |
| C21247 | BRD-K59332007 | linopirdine | KCNQ2; KCNQ3 | Potassium channel blocker | -- | Details |
| C21248 | BRD-K59333713 | BRD-K59333713 | -- | -- | niguldipine-(S)-(+) | Details |
| C21249 | BRD-K59335919 | BRD-K59335919 | -- | -- | -- | Details |
| C21250 | BRD-K59336577 | BRD-K59336577 | -- | -- | -- | Details |
| C21251 | BRD-K59339270 | AH-6809 | -- | -- | -- | Details |
| C21252 | BRD-K59340545 | BRD-K59340545 | -- | -- | -- | Details |
| C21253 | BRD-K59341874 | BRD-K59341874 | -- | -- | -- | Details |
| C21254 | BRD-K59352217 | BRD-K59352217 | -- | -- | -- | Details |
| C21255 | BRD-K59356638 | BRD-K59356638 | -- | -- | -- | Details |
| C21256 | BRD-K59369769 | tozasertib | BCR; AURKA; AURKC; AURKB; FLT3; ABL1; JAK2 | JAK inhibitor; FLT3 inhibitor; Aurora kinase inhibitor; Abl kinase inhibitor | -- | Details |
| C21257 | BRD-K59371957 | BRD-K59371957 | -- | -- | -- | Details |
| C21258 | BRD-K59377703 | BRD-K59377703 | -- | -- | -- | Details |
| C21259 | BRD-K59385073 | BRD-K59385073 | -- | -- | -- | Details |
| C21260 | BRD-K59386816 | BRD-K59386816 | -- | -- | -- | Details |
| C21261 | BRD-K59389251 | BRD-K59389251 | -- | -- | -- | Details |
| C21262 | BRD-K59391348 | lixivaptan | -- | -- | -- | Details |
| C21263 | BRD-K59392211 | BRD-K59392211 | -- | -- | -- | Details |
| C21264 | BRD-K59392325 | BRD-K59392325 | -- | -- | -- | Details |
| C21265 | BRD-K59397033 | BRD-K59397033 | -- | -- | -- | Details |
| C21266 | BRD-K59399000 | BRD-K59399000 | -- | -- | -- | Details |
| C21267 | BRD-K59402582 | BRD-K59402582 | -- | -- | -- | Details |
| C21268 | BRD-K59404663 | BRD-K59404663 | -- | -- | -- | Details |
| C21269 | BRD-K59406868 | NCI-16221 | -- | -- | -- | Details |
| C21270 | BRD-K59419204 | AM-281 | CNR1 | Cannabinoid receptor antagonist | -- | Details |
| C21271 | BRD-K59423635 | BRD-K59423635 | -- | -- | -- | Details |
| C21272 | BRD-K59429476 | PSH-021 | -- | -- | -- | Details |
| C21273 | BRD-K59433843 | ICI-192605 | -- | -- | -- | Details |
| C21274 | BRD-K59434830 | BRD-K59434830 | -- | -- | -- | Details |
| C21275 | BRD-K59436580 | tedizolid | -- | -- | -- | Details |
| C21276 | BRD-K59437706 | BRD-K59437706 | -- | -- | -- | Details |
| C21277 | BRD-K59445060 | BRD-K59445060 | -- | -- | -- | Details |
| C21278 | BRD-K59446585 | BRD-K59446585 | -- | -- | -- | Details |
| C21279 | BRD-K59453031 | BRD-K59453031 | -- | -- | -- | Details |
| C21280 | BRD-K59453266 | BRD-K59453266 | -- | -- | -- | Details |
| C21281 | BRD-K59455917 | BRD-K59455917 | -- | -- | -- | Details |
| C21282 | BRD-K59456551 | methotrexate | DHFR | Dihydrofolate reductase inhibitor | -- | Details |
| C21283 | BRD-K59460069 | BRD-K59460069 | -- | -- | -- | Details |
| C21284 | BRD-K59465228 | BRD-K59465228 | -- | -- | -- | Details |
| C21285 | BRD-K59466999 | BRD-K59466999 | -- | -- | -- | Details |
| C21286 | BRD-K59468384 | BRD-K59468384 | -- | -- | -- | Details |
| C21287 | BRD-K59469039 | AG-879 | -- | -- | tyrphostin-AG-879 | Details |
| C21288 | BRD-K59470558 | BRD-K59470558 | -- | -- | -- | Details |
| C21289 | BRD-K59472190 | BRD-K59472190 | -- | -- | -- | Details |
| C21290 | BRD-K59472400 | BRD-K59472400 | -- | -- | -- | Details |
| C21291 | BRD-K59475561 | BRD-K59475561 | -- | -- | -- | Details |
| C21292 | BRD-K59475795 | BRD-K59475795 | -- | -- | -- | Details |
| C21293 | BRD-K59482768 | BRD-K59482768 | -- | -- | -- | Details |
| C21294 | BRD-K59484021 | BRD-K59484021 | -- | -- | -- | Details |
| C21295 | BRD-K59488055 | BRD-K59488055 | -- | -- | -- | Details |
| C21296 | BRD-K59490275 | SA-419010 | -- | -- | -- | Details |
| C21297 | BRD-K59491389 | BRD-K59491389 | -- | -- | -- | Details |
| C21298 | BRD-K59491482 | BRD-K59491482 | -- | -- | -- | Details |
| C21299 | BRD-K59501784 | SA-419090 | -- | -- | -- | Details |
| C21300 | BRD-K59506194 | targinine | -- | -- | -- | Details |
| C21301 | BRD-K59507567 | BRD-K59507567 | -- | -- | -- | Details |
| C21302 | BRD-K59507746 | BRD-K59507746 | -- | -- | -- | Details |
| C21303 | BRD-K59517185 | BRD-K59517185 | -- | -- | -- | Details |